Marion McCourt - 07 Feb 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Commercial
Signature
/s/**Marion McCourt
Issuer symbol
REGN
Transactions as of
07 Feb 2023
Net transactions value
-$396,580
Form type
4
Filing time
08 Feb 2023, 15:14:27 UTC
Previous filing
03 Feb 2023
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $372,460 +1,000 +4.5% $372.46 23,079 07 Feb 2023 Direct
transaction REGN Common Stock Sale $769,040 -1,000 -4.3% $769.04 22,079 07 Feb 2023 Direct
holding REGN Common Stock 138 07 Feb 2023 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,000 -13% $0.000000 6,650 07 Feb 2023 Common Stock 1,000 $372.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.